Pagoclone clinical trials
How each study uses pagoclone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- pagoclone
- 4
Studies by the year they started
4 studies that test it; most in 2005 (2)
| Year | Studies |
|---|---|
| 2005 | 2 |
| 2006 | 1 |
| 2009 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 1
Endo Pharmaceuticals (3) · Pharmacology Research Institute (1)
Studies
Open first, then newest update. How each study uses pagoclone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- Exploratory Study of Pagoclone in Men With Premature Ejaculation.CompletedPhase 2Endo PharmaceuticalsNCT00370981Written as pagoclone
- EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering StudyCompletedPhase 2Endo PharmaceuticalsNCT00216255Written as Pagoclone
- A Study to Assess the Efficacy and Safety of Pagoclone for Adults With StutteringCompletedPhase 2/3Endo PharmaceuticalsNCT00830154Written as pagoclone
- Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)CompletedPhase 2Pharmacology Research InstituteNCT00239915Written as Pagoclone
Codes
What other systems call pagoclone · ClinicalTrials.gg INT004421
- MeSH (NLM) C447412pagocloneOne source NLM
- UNII (FDA) 38VAG2SA33PAGOCLONEConfirmed FDA, NLM
- NCI Thesaurus C74529PagocloneOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C447412 | pagoclone | One source NLM |
| UNII (FDA) | 38VAG2SA33 | PAGOCLONE | Confirmed FDA, NLM |
| NCI Thesaurus | C74529 | Pagoclone | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.